Avantor® to Feature Global cGMP Supply Chain, Expanded Product Portfolio and Biopharma Expertise at CPhI India 2017

Nov 3, 2017

Avantor® will highlight its distinctive global cGMP manufacturing capabilities and robust portfolio of innovative life sciences materials and solutions at CPhI India 2017 on November 28-30 in Mumbai, India. The company will be exhibiting in Hall 1, booth J-35 at the Bombay Exhibition Centre (BEC). In addition, two Avantor experts will present on key industry topics about streamlining product launches, and new approaches to controlling variability in protein therapeutics. At its exhibit, Avantor representatives will discuss the company’s global cGMP production footprint, which includes cGMP manufacturing and packaging in Panoli, India; three North American cGMP production centers; and enhanced cGMP ...

Read More

GEA Seals the Deal with Brand New Customer at CPhI Worldwide

Nov 3, 2017

GEA is pleased to announce the sale of a PERFORMA™ P rotary tablet press to first-time customer farmatek, a privately owned Turkish pharmaceutical company. During last week’s CPhI trade show in Frankfurt, Germany, GEA and farmatek shook hands to complete the sale of aPERFORMA™ P tablet press. Founded in 1991 to import and introduce pharmaceutical products into Turkish medicine, farmatek began its operations by importing hemophilia, immunoglobulin and intensive care products. Since then, the company has expanded its portfolio with several dermatology, cardiology, urology and surgical products to meet market requirements. The versatile and cost-effective PERFORMA™ P features the exclusive ...

Read More

Supply Chain Wizard Launches Suite of Interconnected Digital Supply Chain Solutions for Pharma Manufacturers, CMOs, 3PLs & Pharmacies

Nov 3, 2017

Supply Chain Wizard (SCW) – a leading full-service global consulting firm specializing in serialization and traceability, along with supply chain strategy and operational transformation programs – has launched a new suite of interconnected digital supply chain solutions for companies in the pharma sector. The visibility, collaboration and productivity solutions are suitable for manufacturers, contract manufacturers, contract packagers , third-party logistics providers (3PLs) / Distributors, and pharmacies.   Centered around looming serialization deadlines in the U.S. (2018), Europe (early 2019) and elsewhere, the solutions set was co-designed & co-developed with Pharma industry leaders to optimize operations for growth, service and efficiency. ...

Read More

BioBeat names 50 female Movers and Shakers in Life Sciences in the East of England

Nov 3, 2017

Karen Livingstone, Director of SBRI Healthcare, was today named as one of the top 50 Movers and Shakers in the BioBeat report (download full report http://www.mws-consulting.co.uk/news-publications/). Karen is the National Director for SBRI Healthcare (http://sbrihealthcare.co.uk/), an NHS Innovation programme run by the Eastern Academic Health Science Network. SBRI Healthcare has shown how to invest public funds for patient benefit. The programme has invested £74 million of NHS England funding into over 200 innovations that are transforming patient care, saving the NHS money and creating successful UK businesses. SBRI Healthcare has evidenced impact on over 704,000 patients to date (with potential ...

Read More

TiGenix strengthens European IP protection around lead development program Cx601

Nov 3, 2017

TiGenix NV (Euronext Brussels and NASDAQ: TIG), an advanced biopharmaceutical company focused on exploiting the anti-inflammatory properties of allogeneic, or donor-derived, stem cells to develop novel therapies for serious medical conditions, today announced that it has further strengthened its IP protection around the company’s lead product Cx601, intended for the treatment of complex perianal fistulas in patients with Crohn’s disease. The use of Cx601 in treating fistulas is protected by European patent EP 2292737 entitled “Use of adipose tissue-derived stromal stem cells in treating fistula”. The validity of this patent has been found undisputed in an opposition proceeding before the ...

Read More